11 results match your criteria: "Department of Surgery Johns Hopkins University School of Medicine Baltimore MD.[Affiliation]"

Article Synopsis
  • Previous studies showed varying practices in peripheral vascular interventions (PVIs) for claudication, but limited data existed on long-term trends; this study aimed to fill that gap over 12 years in the U.S.
  • A retrospective analysis of Medicare claims identified 599,197 PVIs performed, with significant increases in the use of tibial PVI (1% per year) and atherectomy (1.6% per year), along with a shift from hospital settings to outpatient centers (up 4% per year).
  • Total Medicare charges associated with these procedures rose by about $11.98 million each year, highlighting disparities in treatment based on race and a need for better value-based care in claudication
View Article and Find Full Text PDF

Background: Cardiac rehabilitation (CR) is an evidence-based, guideline-recommended intervention for patients recovering from a cardiac event, surgery or procedure that improves morbidity, mortality, and functional status. CR is traditionally provided in-center, which limits access and engagement, most notably among underrepresented racial and ethnic groups due to barriers including cost, scheduling, and transportation access. This study is designed to evaluate the Corrie Hybrid CR, a technology-based, multicomponent health equity-focused intervention as an alternative to traditional in-center CR among patients recovering from a cardiac event, surgery, or procedure compared with usual care alone.

View Article and Find Full Text PDF

Background ATP-sensitive potassium channels are inhibited by ATP and open during metabolic stress, providing endogenous myocardial protection. Pharmacologic opening of ATP potassium channels with diazoxide preserves myocardial function following prolonged global ischemia, making it an ideal candidate for use during cardiac surgery. We hypothesized that diazoxide would reduce myocardial stunning after regional ischemia with subsequent prolonged global ischemia, similar to the clinical situation of myocardial ischemia at the time of revascularization.

View Article and Find Full Text PDF

Background Many hospitalized patients are not administered prescribed doses of pharmacologic venous thromboembolism prophylaxis. Methods and Results In this cluster-randomized controlled trial, all adult non-intensive care units (10 medical, 6 surgical) in 1 academic hospital were randomized to either a real-time, electronic alert-triggered, patient-centered education bundle intervention or nurse feedback intervention to evaluate their effectiveness for reducing nonadministration of venous thromboembolism prophylaxis. Primary outcome was the proportion of nonadministered doses of prescribed pharmacologic prophylaxis.

View Article and Find Full Text PDF

Pancreatic adenocarcinoma is a lethal disease that is projected to become the second most common cause of cancer deaths by 2030. The role of adjuvant therapy after surgical resection has been established by several clinical trials to prolong survival and improve outcomes. Multiagent chemotherapy seems to be the most promising approach to counteract early recurrence and improve survival; however, in the era of precision medicine, patient selection and individualized therapy seems to hold the key to desirable superior outcomes.

View Article and Find Full Text PDF

Patient and graft survival are similar following whole-liver transplantations (WLTs) versus split-liver transplantations (SLTs) among pediatric and adult recipients, yet SLTs are rarely used. We sought to determine the survival benefit associated with accepting a splittable graft offer for SLT versus declining and waiting for a subsequent offer using 2010 to 2018 Scientific Registry of Transplant Recipients (SRTR) data on 928 pediatric and 1814 adult liver transplantation candidates who were ever offered a splittable graft. We compared eventual mortality, regardless of subsequent transplants, between those patients who accepted versus declined a split liver offer with adjustments for Pediatric End-Stage Liver Disease/Model for End-Stage Liver Disease (MELD) scores, diagnosis, and weight among pediatric candidates and matching for MELD score, height, and offer among adult candidates.

View Article and Find Full Text PDF
Article Synopsis
  • * Centers that accepted a higher percentage of OLD graft offers also had better overall outcomes, such as higher transplant rates, lower waitlist mortality, and similar posttransplant survival rates compared to those accepting fewer OLD offers.
  • * Factors influencing acceptance included the center's annual transplant volume and the type of graft offers, with centers that accepted more nationally shared organs being more likely to accept OLD grafts.
View Article and Find Full Text PDF